NLRP3 and colitis: In colitis-associated colorectal cancer, the NLRP3 inflammasome acts as a negative modulator of tumorigenesis [103], because NLRP3-dependent IL-18 production promotes epithelial barrier healing, thereby preventing colorectal cancer progression and metastasis [104,105,106,107,108,109].